These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1301210)

  • 1. High level expression of human apolipoprotein A-I in transgenic rats raises total serum high density lipoprotein cholesterol and lowers rat apolipoprotein A-I.
    Swanson ME; Hughes TE; Denny IS; France DS; Paterniti JR; Tapparelli C; Gfeller P; Bürki K
    Transgenic Res; 1992 May; 1(3):142-7. PubMed ID: 1301210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased prebeta-high density lipoprotein, apolipoprotein AI, and phospholipid in mice expressing the human phospholipid transfer protein and human apolipoprotein AI transgenes.
    Jiang X; Francone OL; Bruce C; Milne R; Mar J; Walsh A; Breslow JL; Tall AR
    J Clin Invest; 1996 Nov; 98(10):2373-80. PubMed ID: 8941656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of human lecithin-cholesterol acyltransferase in transgenic mice. Effect of human apolipoprotein AI and human apolipoprotein all on plasma lipoprotein cholesterol metabolism.
    Francone OL; Gong EL; Ng DS; Fielding CJ; Rubin EM
    J Clin Invest; 1995 Sep; 96(3):1440-8. PubMed ID: 7657816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of human apolipoprotein A-I in transgenic rats and the hyperlipoproteinemia associated with experimental nephrosis.
    Burkey BF; France D; Wang H; Ma X; Brand B; Abuhani C; Diffenderfer MR; Marsh JB; Paterniti JR; Fisher EA
    J Lipid Res; 1995 Jul; 36(7):1463-73. PubMed ID: 7595070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Marked reduction of high density lipoprotein cholesterol in mice genetically modified to lack apolipoprotein A-I.
    Williamson R; Lee D; Hagaman J; Maeda N
    Proc Natl Acad Sci U S A; 1992 Aug; 89(15):7134-8. PubMed ID: 1496008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human apoA-I/C-III/A-IV gene cluster transgenic rabbits: effects of a high-cholesterol diet.
    Recalde D; Baroukh N; Viglietta C; Prince S; Verona J; Vergnes L; Pidoux J; Nazeem Nanjee M; Brites F; Ochoa A; Castro G; Zakin MM; Miller NE; Marie Houdebine L
    FEBS Lett; 2004 Aug; 572(1-3):294-8. PubMed ID: 15304365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High levels of human apolipoprotein A-I and high density lipoproteins in transgenic mice do not enhance efflux of cholesterol from a depot of injected lipoproteins. Relevance to regression of atherosclerosis?
    Stein O; Dabach Y; Hollander G; Ben-Naim M; Halperin G; Stein Y
    Atherosclerosis; 1999 Jun; 144(2):367-74. PubMed ID: 10407497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accumulation of cholestatic lipoproteins in ANIT-treated human apolipoprotein A-I transgenic rats is diminished through dose-dependent apolipoprotein A-I activation of LCAT.
    Chisholm JW; Paterniti JR; Dolphin PJ
    Biochim Biophys Acta; 2000 Sep; 1487(2-3):145-54. PubMed ID: 11018467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased levels of high-density lipoprotein cholesterol are ineffective in inhibiting the development of immune responses to oxidized low-density lipoprotein and atherosclerosis in transgenic rabbits expressing human apolipoprotein (apo) A-I with severe hypercholesterolaemia.
    Boullier A; Hennuyer N; Tailleux A; Furman C; Duverger N; Caillaud JM; Castro G; Fievet C; Fruchart JC; Duriez P
    Clin Sci (Lond); 2001 Mar; 100(3):343-55. PubMed ID: 11222122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transgenic rabbits expressing human apolipoprotein A-I in the liver.
    Duverger N; Viglietta C; Berthou L; Emmanuel F; Tailleux A; Parmentier-Nihoul L; Laine B; Fievet C; Castro G; Fruchart JC; Houbebine LM; Denèfie P
    Arterioscler Thromb Vasc Biol; 1996 Dec; 16(12):1424-9. PubMed ID: 8977445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein analysis in transgenic mice expressing human apolipoprotein (apo) A-I and apo C III: use of micromethods in analysis of lipoprotein system in mice.
    Ito Y
    Hokkaido Igaku Zasshi; 1994 Mar; 69(2):312-26. PubMed ID: 8157256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary cholic acid lowers plasma levels of mouse and human apolipoprotein A-I primarily via a transcriptional mechanism.
    Srivastava RA; Srivastava N; Averna M
    Eur J Biochem; 2000 Jul; 267(13):4272-80. PubMed ID: 10866832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of apolipoprotein E in transgenic mice: marked reduction in plasma lipoproteins except high density lipoprotein and resistance against diet-induced hypercholesterolemia.
    Shimano H; Yamada N; Katsuki M; Shimada M; Gotoda T; Harada K; Murase T; Fukazawa C; Takaku F; Yazaki Y
    Proc Natl Acad Sci U S A; 1992 Mar; 89(5):1750-4. PubMed ID: 1542669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human apolipoproteins A-I and A-II in cell cholesterol efflux: studies with transgenic mice.
    Chiesa G; Parolini C; Canavesi M; Colombo N; Sirtori CR; Fumagalli R; Franceschini G; Bernini F
    Arterioscler Thromb Vasc Biol; 1998 Sep; 18(9):1417-23. PubMed ID: 9743230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-fat, high-cholesterol diet raises plasma HDL cholesterol: studies on the mechanism of this effect.
    Wolf G
    Nutr Rev; 1996 Jan; 54(1 Pt 1):34-5. PubMed ID: 8919697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels.
    Jiang XC; Bruce C; Mar J; Lin M; Ji Y; Francone OL; Tall AR
    J Clin Invest; 1999 Mar; 103(6):907-14. PubMed ID: 10079112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of atherosclerosis development in cholesterol-fed human apolipoprotein A-I-transgenic rabbits.
    Duverger N; Kruth H; Emmanuel F; Caillaud JM; Viglietta C; Castro G; Tailleux A; Fievet C; Fruchart JC; Houdebine LM; Denefle P
    Circulation; 1996 Aug; 94(4):713-7. PubMed ID: 8772693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An interaction between the human cholesteryl ester transfer protein (CETP) and apolipoprotein A-I genes in transgenic mice results in a profound CETP-mediated depression of high density lipoprotein cholesterol levels.
    Hayek T; Chajek-Shaul T; Walsh A; Agellon LB; Moulin P; Tall AR; Breslow JL
    J Clin Invest; 1992 Aug; 90(2):505-10. PubMed ID: 1644921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of expressed human apolipoprotein AI on plasma high density lipoprotein level in transgenic mice].
    Li H; Gu S; She M
    Zhonghua Yi Xue Za Zhi; 1998 Jul; 78(7):531-3. PubMed ID: 10923465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of lipoprotein metabolism by estrogen in inbred strains of mice occurs primarily by posttranscriptional mechanisms.
    Srivastava RA; Krul ES; Lin RC; Schonfeld G
    Mol Cell Biochem; 1997 Aug; 173(1-2):161-8. PubMed ID: 9278267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.